Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $12.5300 (-0.95%) ($12.5300 - $12.5300) on Mon. Aug. 9, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.08% (three month average) | RSI | 42 | Latest Price | $12.5300(-0.95%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.6% a day on average for past five trading days. | Weekly Trend | ATRA declines -1.5% a week on average for past two weeks. | Market Behavior | Normal for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(52%) ARKG(45%) ARKK(45%) IBB(45%) IWO(43%) | Factors Impacting ATRA price | ATRA will decline at least -1.54% in a week (0% probabilities). VIXM(-37%) VXX(-27%) UNG(-12%) TLT(-10%) UUP(-8%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.54% (StdDev 3.08%) | Hourly BBV | -0.6 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $6.26(-50.04%) | Resistance Level | $12.96 | 5 Day Moving Average | $12.6(-0.56%) | 10 Day Moving Average | $12.74(-1.65%) | 20 Day Moving Average | $12.96(-3.32%) | To recent high | -24.4% | To recent low | 1% | Market Cap | $931m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |